Auden Mckenzie Overview

  • Founded
  • 1999
  • Status
  • Acquired/​Merged
  • Employees
  • 49
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Auden Mckenzie General Information


Developer of generic medicines. The company's product portfolio includes molecules in various dosage forms, for treatments across a broad spectrum of therapeutic areas.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Drug Delivery
Primary Office
  • Mckenzie House
  • Bury street, Middlesex
  • Ruislip HA4 7TL
  • England, United Kingdom
+44 01895 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Auden Mckenzie Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Auden Mckenzie‘s full profile, request access.

Request a free trial

Auden Mckenzie Executive Team (3)

Name Title Board Seat Contact Info
Praveen Parepally Chief Technology Officer
Amit Patel Managing Director
Janit Patel Director, Business Development
To view Auden Mckenzie’s complete executive team members history, request access »

Auden Mckenzie Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial